Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade

Increased risk of low birth weight in women with placental malaria associated with P. falciparum VAR2CSA clade

Abstract Pregnancy associated malaria (PAM) causes adverse pregnancy and birth outcomes owing to Plasmodium falciparum accumulation in the placenta. Placental accumulation is mediated by P. falciparum protein VAR2CSA, a leading PAM-specific vaccine target. The extent of its antigen diversity and imp...

Full description

Bibliographic Details
Main Authors:	Jaymin C. Patel, Nicholas J. Hathaway, Christian M. Parobek, Kyaw L. Thwai, Mwayiwawo Madanitsa, Carole Khairallah, Linda Kalilani-Phiri, Victor Mwapasa, Achille Massougbodji, Nadine Fievet, Jeffery A. Bailey, Feiko O. ter Kuile, Philippe Deloron, Stephanie M. Engel, Steve M. Taylor, Jonathan J. Juliano, Nicaise Tuikue Ndam, Steven R. Meshnick
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-04737-y

Similar Items

Plasmodium falciparum VAR2CSA-Specific IgG Subclass Responses Reflect Protection Against Low Birth Weight and Pregnancy-Associated Malaria
by: Bernard Tornyigah, et al.
Published: (2021-04-01)

Neurocognitive outcomes in Malawian children exposed to malaria during pregnancy: An observational birth cohort study.
by: Andrea M Weckman, et al.
Published: (2021-09-01)

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial.
by: Mwayiwawo Madanitsa, et al.
Published: (2016-09-01)

Differential evolution of anti-VAR2CSA- IgG3 in primigravidae and multigravidae pregnant women infected by <it>Plasmodium falciparum</it>
by: Sow Sokhna, et al.
Published: (2008-01-01)

Towards the rational design of a candidate vaccine against pregnancy associated malaria: conserved sequences of the DBL6epsilon domain of VAR2CSA.
by: Cyril Badaut, et al.
Published: (2010-06-01)

Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA.
by: Justin Doritchamou, et al.
Published: (2015-01-01)

Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
by: Nicaise Tuikue Ndam, et al.
Published: (2015-05-01)

Dynamics of Plasmodium falciparum gametocyte carriage in pregnant women under intermittent preventive treatment with sulfadoxine–pyrimethamine in Benin
by: Sayeh Jafari-Guemouri, et al.
Published: (2018-10-01)

Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
by: Robyn E Elphinstone, et al.
Published: (2019-10-01)

Insight into antigenic diversity of VAR2CSA-DBL5ε domain from multiple Plasmodium falciparum placental isolates.
by: Sédami Gnidehou, et al.
Published: (2010-10-01)

Dynamics in the cytoadherence phenotypes of Plasmodium falciparum infected erythrocytes isolated during pregnancy.
by: Justin Doritchamou, et al.
Published: (2014-01-01)

Sequential disruptions to inflammatory and angiogenic pathways and risk of spontaneous preterm birth in Malawian women
by: Andrea M. Weckman, et al.
Published: (2023-06-01)

Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials
by: Julie R Gutman, et al.
Published: (2021-11-01)

Submicroscopic placental infection by non-falciparum Plasmodium spp.
by: Justin Y A Doritchamou, et al.
Published: (2018-02-01)

Towards a vaccine against pregnancy-associated malaria
by: Tuikue Ndam N., et al.
Published: (2008-09-01)

Peripheral blood cell signature and inflammatory responses during pregnancy-associated malaria
by: Ibitokou Samad, et al.
Published: (2012-11-01)

Intermittent preventive treatment with sulphadoxine-pyrimethamine but not dihydroartemisinin-piperaquine modulates the relationship between inflammatory markers and adverse pregnancy outcomes in Malawi.
by: Kaylene Cheng, et al.
Published: (2024-01-01)

Independent Lineages of Highly Sulfadoxine-Resistant Plasmodium falciparum Haplotypes, Eastern Africa
by: Steve M. Taylor, et al.
Published: (2014-07-01)

Optimized Pan-species and speciation duplex real-time PCR assays for Plasmodium parasites detection in malaria vectors.
by: Maurice Marcel Sandeu, et al.
Published: (2012-01-01)

Multiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolates.
by: Adam F Sander, et al.
Published: (2009-08-01)

Expression of the domain cassette 8 Plasmodium falciparum erythrocyte membrane protein 1 is associated with cerebral malaria in Benin.
by: Gwladys I Bertin, et al.
Published: (2013-01-01)

Plasmodium falciparum genetic variation of var2csa in the Democratic Republic of the Congo
by: Robert Verity, et al.
Published: (2018-01-01)

Heterozygous HbAC but not HbAS is associated with higher newborn birthweight among women with pregnancy-associated malaria
by: Marilou Tétard, et al.
Published: (2017-05-01)

VAR2CSA Serology to Detect Plasmodium falciparum Transmission Patterns in Pregnancy
by: Ana Maria Fonseca, et al.
Published: (2019-10-01)

Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration.
by: Madeleine Dahlbäck, et al.
Published: (2006-11-01)

<it>Plasmodium falciparum </it>parasites causing cerebral malaria share variant surface antigens, but are they specific?
by: Rogier Christophe, et al.
Published: (2010-07-01)

Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration.
by: Bich-Tram Huynh, et al.
Published: (2012-01-01)

<it>Plasmodium falciparum </it>population dynamics in a cohort of pregnant women in Senegal
by: Lund Ole, et al.
Published: (2010-06-01)

Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa
by: Patrick G. T. Walker, et al.
Published: (2020-07-01)

Variant surface antigens in cerebral malaria: distinct from others and similar to each other?
by: Lalya Francis, et al.
Published: (2010-10-01)

Malaria associated symptoms in pregnant women followed-up in Benin
by: Massougbodji Achille, et al.
Published: (2011-03-01)

Identification of glycosaminoglycan binding regions in the <it>Plasmodium falciparum </it>encoded placental sequestration ligand, VAR2CSA
by: Theander Thor G, et al.
Published: (2008-06-01)

What Makes a CSA a CSA?
by: Zhenzhong Si, et al.
Published: (2020-07-01)

Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon
by: Nicaise Tuikue Ndam, et al.
Published: (2017-03-01)

CSA + the consumer /
by: Canadian Standards Association
Published: (1970)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
by: Philippe Deloron, et al.
Published: (2010-11-01)

Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in <it>Pichia pastoris</it>
by: Narum David L, et al.
Published: (2009-06-01)

Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?
by: Mukaka, M, et al.
Published: (2016)

Model choices to obtain adjusted risk difference estimates from a binomial regression model with convergence problems: an assessment of methods of adjusted risk difference estimation
by: Mukaka, M, et al.
Published: (2016)

Plasmodium falciparum variability and immune evasion proceed from antigenicity of consensus sequences from DBL6ε; generalization to all DBL from VAR2CSA.
by: Philippe Deloron, et al.
Published: (2013-01-01)